Literature DB >> 18952626

Echocardiographic predictors of functional capacity in endomyocardial fibrosis patients.

Vera M C Salemi1, João J Leite, Michael H Picard, Leila M Oliveira, Soraya F Reis, Jose L B Pena, Charles Mady.   

Abstract

AIMS: Endomyocardial fibrosis (EMF) is a restrictive cardiomyopathy manifested mainly by diastolic heart failure. It is recognized that diastole is an important determinant of exercise capacity. The purpose of this study was to determine whether resting echocardiographic parameters might predict oxygen consumption (VO(2p)) by ergoespirometry and the prognostic role of functional capacity in EMF patients. METHODS AND
RESULTS: A total of 32 patients with biventricular EMF (29 women, 55.3 +/- 11.4 years) were studied by echocardiography and ergoespirometry. The relationship between the echocardiographic indexes and the percentage of predicted VO(2p) (%VO(2p)) was investigated by the 'stepwise' linear regression analysis. The median VO(2p) was 11 +/- 3 mL/kg/min and the %VO(2p) was 53 +/- 9%. There was a correlation of %VO(2p) with an average of A' at four sites of the mitral annulus (A' peak, r = 0.471, P = 0.023), E'/A' of the inferior mitral annulus (r = -0.433, P = 0.044), and myocardial performance index (r = -0.352, P = 0.048). On multiple regression analysis, only A' peak was an independent predictor of %VO(2p) (%VO(2p)= 26.34 + 332.44 x A' peak). EMF patients with %VO(2p)< 53% had an increased mortality rate with a relative risk of 8.47.
CONCLUSION: In EMF patients, diastolic function plays an important role in determining the limitations to exercise and %VO(2p) has a prognostic value.

Entities:  

Mesh:

Year:  2008        PMID: 18952626     DOI: 10.1093/ejechocard/jen297

Source DB:  PubMed          Journal:  Eur J Echocardiogr        ISSN: 1532-2114


  5 in total

1.  Cardiac and peripheral autonomic control in restrictive cardiomyopathy.

Authors:  Ana Luiza C Sayegh; Marcelo R Dos Santos; Adriana O Sarmento; Francis R de Souza; Vera M C Salemi; Viviane T Hotta; Akothirene Cristhina D B Marques; Heidrum H Krämer; Ivani C Trombetta; Charles Mady; Maria Janieire de Nazaré Nunes Alves
Journal:  ESC Heart Fail       Date:  2017-03-30

2.  Characterization of Cardiopulmonary Exercise Testing Variables in Patients with Endomyocardial Fibrosis after Endocardial Resection.

Authors:  Ana Luiza C Sayegh; Marcelo R Dos Santos; Patricia de Oliveira; Fábio Fernandes; Eduardo Rondon; Francis R de Souza; Vera M C Salemi; Maria Janieire de N N Alves; Charles Mady
Journal:  Arq Bras Cardiol       Date:  2017-12       Impact factor: 2.000

3.  Endomyocardial fibrosis of the right ventricle in a patient with schistosomiasis: a case report.

Authors:  Cristhian Espinoza Romero; Ivna Cunha Vieira Lima; Viviane Tiemi Hotta; Edimar Alcides Bocchi; Vera Maria Cury Salemi
Journal:  Eur Heart J Case Rep       Date:  2022-07-28

4.  Does quantitative left ventricular regional wall motion change after fibrous tissue resection in endomyocardial fibrosis?

Authors:  Vera Maria Cury Salemi; Fabio Fernandes; Raquel Sirvente; Luciano Nastari; Leonardo Vieira Rosa; Cristiano A Ferreira; José Luiz Barros Pena; Michael H Picard; Charles Mady
Journal:  Clinics (Sao Paulo)       Date:  2009       Impact factor: 2.365

5.  Plasma cytokine profile in tropical endomyocardial fibrosis: predominance of TNF-a, IL-4 and IL-10.

Authors:  Aline S Bossa; Vera M C Salemi; Susan P Ribeiro; Daniela S Rosa; Ludmila Rodrigues Pinto Ferreira; Suzete C Ferreira; Anna Shoko Nishiya; Charles Mady; Jorge Kalil; Edecio Cunha-Neto
Journal:  PLoS One       Date:  2014-10-10       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.